You are here

Article info

Article menu
Download PDFPDF
ORIGINAL ARTICLE
The risk of developing uterine sarcoma after tamoxifen use

Authors

  • O. Lavie Department of Obstetrics & Gynecology, Division of Gynecology & Oncology, Carmel Medical Center, Haifa, Israel; PubMed articlesGoogle scholar articles
  • O. Barnett-Griness Department of Community Medicine and Epidemiology, CHS National Cancer Control Center, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel; and PubMed articlesGoogle scholar articles
  • S. A. Narod Centre for Research on Women's Health and Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • G. Rennert Department of Community Medicine and Epidemiology, CHS National Cancer Control Center, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel; and PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to: Ofer Lavie, MD, Division of Gynecology & Oncology, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel. Email: olavie{at}zahav.net.il

Citation

Lavie O, Barnett-Griness O, Narod SA, et al
The risk of developing uterine sarcoma after tamoxifen use
International Journal of Gynecologic Cancer 2008;18:352-356.

Publication history

  • First published February 1, 2008.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2008 Blackwell Publishing Ltd.